Otezla (apremilast)

Approved for Psoriatic arthritis (active, in adults), Plaque psoriasis (moderate to severe, in adults who are candidates for phototherapy or systemic therapy), Oral ulcers associated with Behçet's disease (in adults). Apremilast is a phosphodiesterase 4 (PDE4) inhibitor. PDE4 is an enzyme that breaks down cyclic adenosine monophosphate (cAMP), a signaling molecule that regulates inflammation. By…

Loading full data from Know Your Drugs Institute…